Presented by Optimum Strategic Communications and Catalyst Advisors, this guide is your key to Europe’s biggest week in life sciences. Join global investors, executives, and innovators for a packed schedule of conferences, panels, and networking events. Plan ahead, connect smart, and make every moment count!
Significant market inefficiencies have left over USD$30 billion of capital trapped in c.300 listed biotech companies worldwide that have experienced clinical or regulatory setbacks Fund provides efficient mechanism to help investors recoup and recycle trapped cash, while allowing residual science and IP to be developed Fund to be listed on public markets in due course […]
Xeltis is one of only seven companies to successfully pass evaluation phase of EIC Strategic Technologies for Europe Platform (STEP) Scale Up call Funding to support commercialization of its groundbreaking bioresorbable vascular conduits EINDHOVEN, The Netherlands, 8 April 2025 – Xeltis, a leading developer of transformative implants that enable the natural creation of living and […]
Additional funding from new investor Korys, joining existing syndicate members Novo Holdings and Bioqube Ventures, brings total seed financing to €21.5m Funds will be used to further develop Commit’s BiCE platform and move towards drug candidate (DC) selection Eva Van Overmeire, Senior Investment Manager at Korys, also joins Commit’s Board of Directors Mikkel Wandahl Pedersen […]
By Richard Staines, Optimum Strategic Communications It’s just two weeks until the Labour government announces its crucial first budget, which will set the tone for Keir Starmer’s term as prime minister. The government has been busy making its excuses ahead of the announcement. With talk of a £22 billion “Black Hole” in public finances blamed […]
